1. Home
  2. AAUC vs LGND Comparison

AAUC vs LGND Comparison

Compare AAUC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AAUC

Allied Gold Corporation

HOLD

Current Price

$31.89

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$227.24

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAUC
LGND
Founded
N/A
1987
Country
Canada
United States
Employees
2252
68
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AAUC
LGND
Price
$31.89
$227.24
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$247.29
AVG Volume (30 Days)
241.7K
189.3K
Earning Date
03-31-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$94.92
$1.25
Revenue Next Year
$27.93
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$11.40
$98.90
52 Week High
$32.08
$238.31

Technical Indicators

Market Signals
Indicator
AAUC
LGND
Relative Strength Index (RSI) 65.10 62.26
Support Level $30.99 $180.85
Resistance Level $32.08 $227.92
Average True Range (ATR) 0.21 8.74
MACD 0.03 1.97
Stochastic Oscillator 76.58 74.64

Price Performance

Historical Comparison
AAUC
LGND

About AAUC Allied Gold Corporation

Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, the development of new mines, the advancement of its exploration properties, and, targeting other consolidation opportunities with a focus on Africa.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: